Dr. Antonio Santillan-Gomez
Claim this profileTexas Oncology - San Antonio (USOR)
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
6 reported clinical trials
11 drugs studied
Area of expertise
1Ovarian Cancer
FRα positive
BRCA2 negative
BRCA1 negative
2Fallopian Tube Cancer
FRα positive
Affiliated Hospitals
Clinical Trials Antonio Santillan-Gomez is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Luveltamab Tazevibulin
for Ovarian Cancer
A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1.
Recruiting1 award Phase 2 & 38 criteria
More about Antonio Santillan-Gomez
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Antonio Santillan-Gomez has experience with
- Mirvetuximab Soravtansine
- Paclitaxel
- Pegylated Liposomal Doxorubicin
- Topotecan
- Alpelisib
- Olaparib
Breakdown of trials Antonio Santillan-Gomez has run
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Neoplasm
Peritoneal Carcinomatosis
Allergic Reaction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Antonio Santillan-Gomez specialize in?
Antonio Santillan-Gomez focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved FRα positive patients, or patients who are BRCA2 negative.
Is Antonio Santillan-Gomez currently recruiting for clinical trials?
Yes, Antonio Santillan-Gomez is currently recruiting for 2 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Antonio Santillan-Gomez has studied deeply?
Yes, Antonio Santillan-Gomez has studied treatments such as Mirvetuximab Soravtansine, Paclitaxel, Pegylated liposomal doxorubicin.
What is the best way to schedule an appointment with Antonio Santillan-Gomez?
Apply for one of the trials that Antonio Santillan-Gomez is conducting.
What is the office address of Antonio Santillan-Gomez?
The office of Antonio Santillan-Gomez is located at: Texas Oncology - San Antonio (USOR), San Antonio, Texas 78240 United States. This is the address for their practice at the Texas Oncology - San Antonio (USOR).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.